Spiramycin resistance in human periodontitis microbiota

Anaerobe

Volumn 17, Issue 4, 2011, Pages 201-205

  Rams, Thomas E ^a,b,c   Dujardin, Sebastien ^a   Sautter, Jacqueline D ^a   Degener, John E ^c   van Winkelhoff, Arie J ^c  

^a TEMPLE UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Amoxicillin; In vitro; Metronidazole; Periodontitis; Spiramycin; Subgingival

Indexed keywords

AMOXICILLIN; METRONIDAZOLE; SPIRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CAMPYLOBACTER RECTUS; CONTROLLED STUDY; FUSOBACTERIUM NUCLEATUM; IN VITRO STUDY; MOUTH PLAQUE; NONHUMAN; PARVIMONAS MICRA; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; PREVOTELLA NIGRESCENS; PRIORITY JOURNAL; STREPTOCOCCUS CONSTELLATUS; STREPTOCOCCUS INTERMEDIUS; TANNERELLA FORSYTHENSIS; UNITED STATES;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; METAGENOME; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PERIODONTITIS; SPIRAMYCIN;

FORSYTHIA; FUSOBACTERIUM NUCLEATUM; PORPHYROMONAS GINGIVALIS; PREVOTELLA; STREPTOCOCCUS CONSTELLATUS; STREPTOCOCCUS INTERMEDIUS; TANNERELLA FORSYTHENSIS;

EID: 80051937443     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2011.03.017     Document Type: Article

References (46)

1. Rubinstein E., Keller N. Spiramycin renaissance. J Antimicrob Chemother 1998, 42:572-576.
2. Rotzetter P.A., Le Liboux A., Pichard E., Cimasoni G. Kinetics of spiramycin/metronidazole (Rodogyl) in human gingival crevicular fluid, saliva and blood. J Clin Periodontol 1994, 21:595-600.
3. Al-Haroni M., Skaug N. Incidence of antibiotic prescribing in dental practice in Norway and its contribution to national consumption. J Antimicrob Chemother 2007, 59:1161-1166.
4. Rodriguez-Núñez A., Cisneros-Cabello R., Velasco-Ortega E., Llamas-Carreras J.M., Tórres-Lagares D., Segura-Egea J.J. Antibiotic use by members of the Spanish endodontic society. J Endod 2009, 35:1198-1203.
5. Sixou J.L., Magaud C., Jolivet-Gougeon A., Cormier M., Bonnaure-Mallet M. Evaluation of the mandibular third molar pericoronitis flora and its susceptibility to different antibiotics prescribed in France. J Clin Microbiol 2003, 41:5794-5797.
6. Bain C.A., Beagrie G.S., Bourgoin J., Delorme F., Holthuis A., Landry R.G., et al. The effects of spiramycin and/or scaling on advanced periodontitis in humans. J Can Dent Assoc 1994, 60:209-217.
7. Mashimo P.A., Yamamoto Y., Slots J., Evans R.T., Genco R.J. In vitro evaluation of antibiotics in the treatment of periodontal disease. Pharmacol Ther Dent 1981, 6:45-56.
8. Baker P.J., Slots J., Genco R.J., Evans R.T. Minimal inhibitory concentrations of various antimicrobial agents for human oral anaerobic bacteria. Antimicrob Agents Chemother 1983, 24:420-424.
9. Baker P.J., Evans R.T., Slots J., Genco R.J. Antibiotic susceptibility of anaerobic bacteria from the human oral cavity. J Dent Res 1985, 64:1233-1244.
10. Quee T.C., Roussou T., Chan E.C. In vitro activity of rodogyl against putative periodontopathic bacteria. Antimicrob Agents Chemother 1983, 24:445-447.
11. Mouton C., Dextraze L., Mayrand D. Susceptibility of potential periodontopathic bacteria to metronidazole, spiramycin and their combination. J Biol Buccale 1984, 12:17-26.
12. Chan E.C., al-Joburi W., Cheng S.L., Delorme F. In vitro susceptibilities of oral bacterial isolates to spiramycin. Antimicrob Agents Chemother 1989, 33:2016-2018.
13. Williams J.D., Maskell J.P., Shain H., Chrysos G., Sefton A.M., Fraser H.Y., et al. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms. J Antimicrob Chemother 1992, 30:27-37.
14. Andrés M.T., Chung W.O., Roberts M.C., Fierro J.F. Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain. Antimicrob Agents Chemother 1998, 42:3022-3023.
15. Madinier I.M., Fosse T.B., Hitzig C., Charbit Y., Hannoun L.R. Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans. J Periodontol 1999, 70:888-892.
16. Lakhssassi N., Elhajoui N., Lodter J.P., Pineil J.L., Sixou M. Antimicrobial susceptibility variation of 50 anaerobic periopathogens in aggressive periodontitis: an interindividual variability study. Oral Microbiol Immunol 2005, 20:244-252.
17. Poulet P.P., Duffaut D., Barthet P., Brumpt I. Concentrations and in vivo antibacterial activity of spiramycin and metronidazole in patients with periodontitis treated with high-dose metronidazole and the spiramycin/metronidazole combination. J Antimicrob Chemother 2005, 55:347-351.
18. van Winkelhoff A.J., Herrera D., Oteo A., Sanz A. Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain. J Clin Periodontol 2005, 32:893-898.
19. Walker C.B. The acquisition of antibiotic resistance in the periodontal microflora. Periodontol 2000 1996, 10:79-88.
20. Armitage G.C. Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000 2004, 34:9-21.
21. Möller A.J.R. Microbiological examination of root canals and periapical tissues of human teeth. Odontol Tidskr 1966, 74:1-380.
22. Dahlén G., Pipattanagovit P., Rosling B., Möller A.J.R. A comparison of two transport media for saliva and subgingival samples. Oral Microbiol Immunol 1993, 8:375-382.
23. Slots J., Rams T.E., Listgarten M.A. Yeasts, enteric rods and pseudomonads in the subgingival flora of severe adult periodontitis. Oral Microbiol Immunol 1988, 3:47-52.
24. Hammond B.F., Mallonee D. A selective/differential medium for Wolinella recta. J Dent Res 1988, 67:327.
25. Slots J. Selective medium for isolation of Actinobacillus actinomycetemcomitans. J Clin Microbiol 1982, 15:606-609.
26. Comité de l'Antibiogramme de la Société Française de Microbiologie, Les recommandations du comité de l'antibiogramme 2010, Recommandations, Last accessed 11/27/2010 at. http://www.sfm.asso.fr/.
27. Methods for antimicrobial susceptibility testing of anaerobic bacteria, approved standard 2007, Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, CLSI document M11-A7. 7th ed.
28. Rams T.E., Listgarten M.A., Slots J. Utility of 5 major putative periodontal pathogens and selected clinical parameters to predict periodontal breakdown in patients on maintenance care. J Clin Periodontol 1996, 23:346-354.
29. Rams T.E., Feik D., Young V., Hammond B.F., Slots J. Enterococci in human periodontitis. Oral Microbiol Immunol 1992, 7:249-252.
30. Rams T.E., Feik D., Listgarten M.A., Slots J. Peptostreptococcus micros in human periodontitis. Oral Microbiol Immunol 1992, 7:1-6.
31. Rams T.E., Feik D., Slots J. Staphylococci in human periodontal diseases. Oral Microbiol Immunol 1990, 5:29-32.
32. Brazier J.S. Yellow fluorescence of fusobacteria. Lett Appl Microbiol 1986, 2:125-126.
33. Alcoforado G.A.P., McKay T.L., Slots J. Rapid method for detection of lactose fermenting oral microorganisms. Oral Microbiol Immunol 1987, 2:35-38.
34. Clarridge J.E., Osting C., Jalali M., Osborne J., Waddington M. Genotypic and phenotypic characterization of "Streptococcus milleri" group isolates from a Veterans Administration hospital population. J Clin Microbiol 1999, 37:3681-3687.
35. Rams T.E., Feik D., Slots J. Campylobacter rectus in human periodontitis. Oral Microbiol Immunol 1993, 8:230-235.
36. Feres M., Haffajee A.D., Goncalves C., Allard K.A., Som S., Smith C., et al. Systemic doxycycline administration in the treatment of periodontal infections (II). Effect on antibiotic resistance of subgingival species. J Clin Periodontol 1999, 26:784-792.
37. van Winkelhoff A.J., Herrera Gonzales D., Winkel E.G., Dellemijn-Kippuw N., Vandenbroucke-Grauls C.M., Sanz M. Antimicrobial resistance in the subgingival microflora in patients with adult periodontitis. A comparison between the Netherlands and Spain. J Clin Periodontol 2000, 27:79-86.
38. Socransky S.S., Haffajee A.D., Cugini M.A., Smith C., Kent R.L. Microbial complexes in subgingival plaque. J Clin Periodontol 1998, 25:134-144.
39. van Winkelhoff A.J., Rams T.E., Slots J. Systemic antibiotic therapy in periodontics. Periodontol 2000 1996, 10:45-78.
40. Roche Y., Yoshimori R.N. In-vitro activity of spiramycin and metronidazole alone or in combination against clinical isolates from odontogenic abscesses. J Antimicrob Chemother 1997, 40:353-357.
41. Roberts M.C. Distribution of macrolide, lincosamide, streptogramin, ketolide and oxazolidinone (MLSKO) resistance genes in gram-negative bacteria. Curr Drug Targets Infect Disord 2004, 4:207-215.
42. Roberts M.C. Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes. FEMS Microbiol Lett 2008, 282:147-159.
43. Lewis M.A., MacFarlane T.W., McGowan D.A. Reliability of sensitivity testing of primary culture of acute dentoalveolar abscess. Oral Microbiol Immunol 1988, 3:177-180.
44. van Winkelhoff A.J., Winkel E.G. Antibiotics in periodontics: right or wrong?. J Periodontol 2009, 80:1555-1558.
45. Quee T.C., Chan E.C., Clark C., Lautar-Lemay C., Bergeron M.J., Bourgouin J., et al. The role of adjunctive Rodogyl therapy in the treatment of advanced periodontal disease. A longitudinal clinical and microbiologic study. J Periodontol 1987, 58:594-601.
46. Machtei E.E., Christersson L.A., Zambon J.J., Hausmann E., Grossi S.G., Dunford R., et al. Alternative methods for screening periodontal disease in adults. J Clin Periodontol 1993, 20:81-87.